The role of smoking in the mechanisms of development of chronic obstructive pulmonary disease and atherosclerosis
S Kotlyarov - International Journal of Molecular Sciences, 2023 - mdpi.com
Tobacco smoking is a major cause of chronic obstructive pulmonary disease (COPD) and
atherosclerotic cardiovascular disease (ASCVD). These diseases share common …
atherosclerotic cardiovascular disease (ASCVD). These diseases share common …
Expiratory Venous Volume and Arterial Tortuosity are Associated with Disease Severity and Mortality Risk in Patients with COPD: Results from COSYCONET
Purpose The aim of this study was to evaluate the association between computed
tomography (CT) quantitative pulmonary vessel morphology and lung function, disease …
tomography (CT) quantitative pulmonary vessel morphology and lung function, disease …
Midregional proatrial naturetic peptide (MRproANP) and copeptin (COPAVP) as predictors of all-cause mortality in recently diagnosed mild to moderate COPD …
S Fähndrich, C Herr, S Teuteberg, P Alter, S Söhler… - Respiratory …, 2024 - Springer
Background MRproANP and COPAVP are prognostic markers for mortality in chronic
obstructive pulmonary disease (COPD). Furthermore, these biomarkers predict mortality due …
obstructive pulmonary disease (COPD). Furthermore, these biomarkers predict mortality due …
Statins did not reduce the frequency of exacerbations in individuals with COPD and cardiovascular comorbidities in the COSYCONET cohort
N Frantzi, XP Nguyen, C Herr, P Alter, S Söhler… - Respiratory …, 2024 - Springer
Background The evidence regarding effects of statins on exacerbation risk in COPD remains
controversial. Previous studies often excluded patients with cardiovascular comorbidities …
controversial. Previous studies often excluded patients with cardiovascular comorbidities …
Development and validation of a nomogram for assessing survival in acute exacerbation of chronic obstructive pulmonary disease patients
N Wang, M Li, G Wang, L Lv, X Yu, X Cheng… - BMC Pulmonary …, 2024 - Springer
Background Early prediction of survival of hospitalized acute exacerbations of chronic
obstructive pulmonary disease (AECOPD) patients is vital. We aimed to establish a …
obstructive pulmonary disease (AECOPD) patients is vital. We aimed to establish a …
Not All Quiet on the Atherosclerosis Front
K Schäfer - International Journal of Molecular Sciences, 2023 - mdpi.com
In recent decades, research has identified the key cellular processes that take place during
atherosclerotic plaque development and progression, including endothelial dysfunction …
atherosclerotic plaque development and progression, including endothelial dysfunction …
[HTML][HTML] Airway Disorders as Predictive Factors of Exacerbations in Asthma and COPD
H Kume, N Watanabe, Y Suzuki - Airway Management in …, 2023 - intechopen.com
Asthma and chronic obstructive pulmonary disease (COPD) are heterogenous diseases in
the respiratory system. Since wheezing, reduced FEV 1, eosinophilic airway inflammation …
the respiratory system. Since wheezing, reduced FEV 1, eosinophilic airway inflammation …
Chronic obstructive pulmonary disease: exacerbations and mortality: Prognostic value of biomarkers and comorbidities
J Ellingsen - 2024 - diva-portal.org
Background: Chronic obstructive pulmonary disease (COPD) is a major cause of morbidity
and mortality. COPD is associated with systemic inflammation, and comorbidities are …
and mortality. COPD is associated with systemic inflammation, and comorbidities are …
Vaccine Prevention of Pneumococcal Infection Among Patients With Chronic Obstructive Pulmonary Disease and Coronary Heart Disease–-A 10-year Horizon of …
GL Ignatova, SN Avdeev, VN Antonov, EV Blinova… - 2024 - researchsquare.com
Vaccine Prevention of Pneumococcal Infection Among Patients With Chronic Obstructive
Pulmonary Disease and Coronary Heart Diseas Page 1 Page 1/24 Vaccine Prevention of …
Pulmonary Disease and Coronary Heart Diseas Page 1 Page 1/24 Vaccine Prevention of …